[CLINICAL STUDY OF A NEW COMPLEX HYPOTENSIVE DRUG COMBINATION].
D000959:Antihypertensive Agents; D001161:Arteriosclerosis; D002219:Carbamates; D002561:Cerebrovascular Disorders; D003327:Coronary Disease; D003925:Diabetic Angiopathies; D004338:Drug Combinations; D006801:Humans; D006830:Hydralazine; D006852:Hydrochlorothiazide; D006973:Hypertension; D006977:Hypertension, Renal; D008103:Liver Cirrhosis; D011188:Potassium
D000959:Antihypertensive Agents; D002219:Carbamates; D004338:Drug Combinations; D006852:Hydrochlorothiazide; D006830:Hydralazine; D011188:Potassium
ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; DIABETIC ANGIOPATHIES; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTENSION, RENAL; LIVER CIRRHOSIS; MEBUTAMATE; POTASSIUM
STUDIO CLINICO DI UNA NUOVA ASSOCIAZIONE IPOTENSIVA COMPLESSA.